Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03008356 · ClinicalTrials.gov registry record · Phase 2
L-carnitine for Fatigue in COPD
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT03008356: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT03008356 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03008356, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely available as an over-the-counter ergogenic aid will improve wellbeing and function measured by questionnaires in patient with chronic obstructive pulmonary disease (COPD). based on our review of literature that addition of health coaching (HC) to L-carnitine will yield greater gains.
Interventions
- DIETARY_SUPPLEMENT Placebo capsules
- DIETARY_SUPPLEMENT L-carnitine 1000 mg twice daily
- BEHAVIORAL Weekly health coaching calls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-01 |
| Est. Completion | 2018-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03008356
The ClinicalTrials.gov registry entry for NCT03008356 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo capsules is the first listed.
NCT03008356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03008356 about?
NCT03008356 is a clinical study titled "L-carnitine for Fatigue in COPD". supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely available as an over-the-counter ergogenic aid will improve wellbeing and function measured by questionnaires in patient with chronic obstructive pulmonary disease (...
What is the current status of trial NCT03008356?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2017-01. Estimated completion is 2018-02.
What interventions are being tested in trial NCT03008356?
The interventions under investigation include: Placebo capsules (DIETARY_SUPPLEMENT), L-carnitine 1000 mg twice daily (DIETARY_SUPPLEMENT), Weekly health coaching calls (BEHAVIORAL).
Who is sponsoring clinical trial NCT03008356?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.